Reinforcing effects of methamphetamine in planarians

NeuroReport

Volumn 11, Issue 11, 2000, Pages 2511-2513

  Kusayama, Taichi ^a   Watanabe, Shigeru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Conditioned place preference; Dopamine agonist; Dopamine antagonist; Haloperidol; Methamphetarnine; Planarians; Reinforcing effects; SCH23390; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE RECEPTOR; HALOPERIDOL; METHAMPHETAMINE; SERENES; SULPIRIDE;

ARTICLE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; TURBELLARIA;

EID: 0034601408     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200008030-00033     Document Type: Article

References (22)

1. 1. Deneau G, Yanagida T and Seevers MH. Psychopharmacologia 16, 30-48 (1969).
2. 2. Pickens R and Harris WC. Psychopharmacologia 12, 158-163 (1968).
3. 3. Winsauer PJ and Thompson DM. Pharmac Biochem Behav 40, 41-52 (1991).
4. 4. Lett BT and Grant VL. Pharmacol Biochem Behav 32, 355-356 (1989).
5. 5. Hoffmeister F. J Pharmacol Exp Ther 192, 468-477 (1976).
6. 6. Johnston RN, Shaw C, Halton DW et al. Biochem Biophys Res Commun 209, 689-697 (1995).
7. 7. Sarnat HB and Netsky MG. Can J Neurol Sci 12, 296-302 (1985).
8. 8. Schaeffer DJ. Ecotoxicol Environ Saf 25, 1-18 (1993).
9. 9. Krichinskaia EB and Efimova GV. Ontogenez 9, 510-514 (1978).
10. 10. Welsh JH and Williams LD. J Comp Neurol 138, 103-115 (1970).
11. 11. Venturini G, Carolei A, Palladini G et al. Comp Biochem Physiol 74, 23-25 (1983).
12. 12. Carolei A, Margotta V and Palladini G. Neuropsychology 1, 355-364 (1975).
13. 13. Franquinet R. J Embryol Exp Morphol 51, 85-95 (1979).
14. 14. Tiras KhP. Ontogenez 9, 262-268 (1978).
15. 15. Palladini G, Ruggeri S, Stocchi F et al. Comp Biochem Physiol 115, 41-45 (1996).
16. 16. Margotta V, Caronti B, Meco G et al. Eur J Histochem 41, 223-230 (1997)
17. 17. Venturini G, Stocchi F, Margotta M et al. Neuropharmacology 28, 1377-1382 (1989).
18. 18. Caine SB and Koob GF. J Pharmacol Exp Ther 270, 209-218 (1994).
19. 19. Miner LL, Drago J, Chamberlain PM et al. Neuroreport 6, 2314-2316 (1995).
20. 20. Morency MA and Benninger RJ. Brain Res 399, 33-41 (1986).
21. 21. Kimmel HD and Garrigan HA. J Exp Psychol 101, 343-347 (1973).
22. 22. Hyden H, Egyhazi E, John ER, Bartlett F. J Neurochem 16, 813-821 (1969).